Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Maxim Group Downgrades Palisade Bio to Hold

Maxim Group analyst Naz Rahman downgrades Palisade Bio (NASDAQ:PALI) from Buy to Hold.
byBenzinga Newsdesk
August 19, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Maxim Group analyst Naz Rahman downgrades Palisade Bio (NASDAQ:PALI) from Buy to Hold.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Bruker Corp Preliminary Expectation For Revenue For Q4 2022 To Be Up Low Single Digits % YoY, A Result Of Organic Growth Of Mid-To-High Single Digits % YoY; Initial Guidance For 2023 For Organic Revenue Growth Up Mid-To-High Single Digit % YoY

By Benzinga Newsdesk
January 9, 12:09 PM
On January 9, 2023 during its scheduled presentation at the 41st Annual J.P. Morgan Healthcare Conference, Bruker Corporation (the “Company”) stated that its current preliminary expectation for revenue for

BRKR